Bona Film Group Secures Investment From Fosun International

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bona Film Group Secures Investment From Fosun International Limited

BEIJING, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Bona Film Group Limited ("Bona" or the "Company") (Nasdaq: BONA ), a leading film distributor and vertically integrated film company in China, today announced that the Company has secured an investment from Fosun Group (Fosun International Limited, 00656.HK, and its subsidiaries) ("Fosun"), a leading, large-scale group with a focus on China's growth momentum in areas such as insurance, industrial operations, property development, investment and asset management.

Under the investment agreement, Fosun will acquire 2,000,000 Bona ordinary shares, representing a 6.4% equity stake in the Company, at an average price of $10.40 per share, or $5.20 per American Depositary Share. Fosun acquired the shares from Matrix Partners China Funds and some of Bona's pre-IPO shareholders. Bona's financial investor Matrix Partners China Funds will have exited its position post this transaction.

"We are very pleased to announce this investment by one of the leading large-scale groups in China," said Mr. Dong Yu. "Fosun has extensive experience and past successes in multiple areas, including property development in many major Chinese cities, and we believe this investment will create meaningful synergies between the two parties."

"Since our IPO in 2010, we have developed our business tremendously and made important progress to diversify our ownership structure by bringing in News Corporation as our strategic investor in May, 2012. This investment from Fosun represents yet another milestone for Bona's ownership structure enhancement. China's movie theater space is amid an exciting and crucial period of growth and we look forward to becoming a leading theater operator in China with the support of our investors and partners," said Mr. Dong Yu.

As a result of this transaction, Mr. Yu's ownership will be reduced to 7,552,506 ordinary shares (not including options to purchase 922,017 ordinary shares), representing approximately 24.1% of the Company's ordinary shares outstanding. The transaction is expected to close in the next 10 days and is subject to customary closing conditions.

About Bona Film Group Limited

Bona Film Group Limited (Nasdaq: BONA ) is a leading film distributor in China, with an integrated business model encompassing film distribution, film production, film exhibition and talent representation. Bona distributes films to Greater China, Korea, Southeast Asia, the United States and Europe, invests and produces movies in a variety of genres, owns and operates twenty movie theaters and manages a range of talented and popular Chinese artists.

For more information about Bona, please visit http://www.bonafilm.cn .

To be added to Bona's email list to receive Company news, please send your request to bona@tpg-ir.com .

The Bona Film Group Limited logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=15750

Forward Looking Statements

This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties, Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

In China: Ms. Lingzi Gui Bona Film Group Limited Tel: +86-10-5631-0700*398 Email: In the U.S.: The Piacente Group, Inc. Investor Relations Lee Roth Tel: (212) 481-2050 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 14

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 9

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 9

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Cartier Faces Class Action Suit Over Warranty Practices

Updated Category News Views 801

Overview of the Class Action Lawsuit Against Cartier A class action lawsuit is currently drawing attention from both consumers and legal experts due to serious allegations against the luxury jewelry brand, Cartier. The lawsuit, initiated by Plaintiff Daniel J. Voelker, was filed recently and focuses on claims that Cartier has failed to honor written warranties for certain...

Continue Reading
Revolutionizing Hotel Sales: Canary Technologies' New Hub

Updated Category News Views 160

Revolutionizing Hotel Sales with AI Technology Canary Technologies has launched an innovative Sales & Catering Payments Hub that empowers hotel teams to manage and close contracts more efficiently. This groundbreaking platform allows Sales & Catering teams to expedite their processes and ensure they receive payments smoothly. Streamlining Hotel Operations for Greater...

Continue Reading
Exploring The RealReal's Current Growth and Future Potential

Updated Category News Views 192

Understanding The Surge of The RealReal Inc. The RealReal Inc. (NASDAQ: REAL) has gained significant attention recently, with its stock rallying over 35% following a favorable earnings report. This surge appears to reflect underlying structural changes within the company, raising questions about the momentum and what it signifies for the future of the stock. The Cakra...

Continue Reading
Silly Nice Expands Reach: Now in 60 NY Dispensaries

Updated Category News Views 53

Silly Nice Expands Across New York's Dispensaries In less than four months since its launch, Silly Nice, a Black and Veteran-owned cannabis brand, has significantly transformed its presence in the New York cannabis market. Now available in more than 60 dispensaries across the state, Silly Nice is thriving thanks to its commitment to quality products and community...

Continue Reading
Aker ASA Set to Announce Financial Results and Future Outlook

Updated Category News Views 124

Aker ASA Set to Reveal Third Quarter Financial Results OSLO, Norway — Aker ASA is excited to announce the publication of its financial results for the third quarter of 2025. The highly anticipated event is scheduled for a Tuesday morning presentation on November 4, 2025. The financial results will be available at 07:00 CET, providing stakeholders with crucial insights...

Continue Reading